As filed with the Securities and Exchange Commission on May 9, 2016

Registration No. 333-

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM S-8

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

Verastem, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

2012 Incentive Plan

(Full title of the plan)

 

Robert Forrester
President and Chief Executive Officer
Verastem, Inc.

117 Kendrick St., Suite 500

Needham, MA 02494

(781) 292-4200

(Name, address, and telephone number, including area code, of agent for service)

 

With copies to:

Marko S. Zatylny

Ropes & Gray LLP

Prudential Tower

800 Boylston Street

Boston, MA 02199

(617) 951-7000

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See definition of “accelerated filer”, “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

 

CALCULATION OF REGISTRATION FEE

Title of each class of securities to be registered		Amount to be registered (1)		Proposed maximum offering price per share (2)			Proposed maximum aggregate offering price (2)			Amount of registration fee
Common Stock, $0.0001 par value per share		1,299,544 shares		$	1.52		$	1,968,809.16		$	198.26

 

(1)         This Registration Statement covers an aggregate of 1,299,544 shares of the Registrant’s Common Stock, par value $0.0001 per share (the “Common Stock”) reserved for issuance under the Registrant’s 2012 Incentive Plan and includes shares that may be added in the future pursuant to the “evergreen” provisions of the Registrant’s 2012 Incentive Plan.  The “evergreen” provision provides that on each January 1 an additional number of shares equal to the lesser of (i) 1,285,714 shares of Common Stock, (ii) 4% of the then-outstanding shares of the Registrant or (iii) an amount determined by the board of directors of the Registrant will be added to the shares authorized for issuance under the 2012 Incentive Plan.  In addition, pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers such additional shares of Common Stock as may be issued to prevent dilution from stock splits, stock dividends and similar transactions.

 

(2)         Pursuant to Rules 457(c) and 457(h)(1) under the Securities Act, the proposed maximum offering price per share and the maximum aggregate offering price for the shares have been calculated solely for the purpose of computing the registration fee on the basis of the average high and low prices of the Common Stock as reported by the Nasdaq Global Market on May 3, 2016 to be $1.57 and $1.46, respectively.

 

 

 

EXPLANATORY NOTE

 

This Registration Statement on Form S-8 is being filed to register an additional 1,299,544 shares under the Registrant’s 2012 Incentive Plan. Pursuant to Instruction E to Form S-8, the Registrant incorporates by reference, except to the extent supplemented, amended or superseded by the information set forth herein, into this Registration Statement the entire contents of its Registration Statement on Form S-8 (File No. 333-180475) filed with the Securities and Exchange Commission on March 30, 2012.

 

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 5.  Interests of Named Experts and Counsel.

 

Not applicable.

 

Item 8.  Exhibits.

 

See the Exhibit Index following the signature page.

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Needham, Commonwealth of Massachusetts on May 9, 2016.

 

	VERASTEM, INC.
	By:	/s/ Robert Forrester
		Robert Forrester
		President and Chief Executive Officer

 

POWER OF ATTORNEY

 

Each person whose signature appears below constitutes and appoints Robert Forrester and Joseph Chiapponi, and each of them singly, either of whom may act without the joinder of the other, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto, and other documents in connection therewith with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them singly, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.

 

SIGNATURES		TITLE		DATE
/s/  Robert Forrester		President, Chief Executive Officer		May 9, 2016
Robert Forrester		(Principal executive officer) and Director
/s/  Joseph Chiapponi		Vice President, Finance		May 9, 2016
Joseph Chiapponi		(Principal financial and accounting officer)
/s/ Henri Termeer		Director		May 9, 2016
Henri Termeer
/s/ Timothy Barberich		Director		May 9, 2016
Timothy Barberich
/s/  Paul A. Friedman, M.D.		Director		May 9, 2016
Paul A. Friedman, M.D.
/s/  Michael Kauffman, M.D., Ph.D.		Director		May 9, 2016
Michael Kauffman, M.D., Ph.D.
/s/  Alison Lawton		Director		May 9, 2016
Alison Lawton

 

3

 

/s/  S. Louise Phanstiel		Director		May 9, 2016
S. Louise Phanstiel
/s/Stephen A. Sherwin, M.D.		Director		May 9, 2016
Stephen A. Sherwin, M.D.
/s/  Christoph Westphal, M.D., Ph.D.		Director		May 9, 2016
Christoph Westphal, M.D., Ph.D.

 

4

 

EXHIBIT INDEX

 

Exhibit		Description
4.1		Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2011, filed by the Registrant with the Securities and Exchange Commission on March 30, 2012)
4.2		Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.4 to Amendment No. 3 to the Registration Statement on Form S-1 filed by the Registrant with the Securities and Exchange Commission on January 13, 2012)
4.3		2012 Incentive Plan (incorporated by reference to Exhibit 10.2 to Amendment No. 3 to the Registration Statement on Form S-1 filed by the Registrant with the Securities and Exchange Commission on January 13, 2012)
5.1		Opinion of Ropes & Gray LLP (filed herewith)
23.1		Consent of Ropes & Gray LLP (included in Exhibit 5.1)
23.2		Consent of Ernst & Young LLP (filed herewith)
24.1		Power of attorney (included on the signature page of this Registration Statement under the caption “Power of Attorney”)

 

5